Correction to Lancet Infect Dis 2025; published online Oct 10. https://doi.org/10.1016/S1473-3099(25)00482-7

Schilling WHK, Jittamala P, Wongnak P, et al. Antiviral efficacy of oral ensitrelvir versus oral ritonavir-boosted nirmatrelvir in COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial. Lancet Infect Dis 2025; published online Oct 10. DOI:https://doi.org/10.1016/S1473-3099(25)00482-7—In this Article, Tanatchakorn Asawasriworanan's qualification was corrected to MSc, and reference number 6 was updated to “Parienti JJ, de Grooth HJ. Clinical relevance of nasopharyngeal SARS-CoV-2 viral load reduction in outpatients with COVID-19.